Narayan Prabhu - Reviva Pharmaceuticals Chief Officer
| RVPHW Stock | USD 0.23 0.04 21.05% |
Insider
Narayan Prabhu is Chief Officer of Reviva Pharmaceuticals Holdings
| Age | 52 |
| Address | 10080 N. Wolfe Road, Cupertino, CA, United States, 95014 |
| Phone | 408-501-8881 |
| Web | https://www.revivapharma.com |
Narayan Prabhu Latest Insider Activity
Tracking and analyzing the buying and selling activities of Narayan Prabhu against Reviva Pharmaceuticals stock is an integral part of due diligence when investing in Reviva Pharmaceuticals. Narayan Prabhu insider activity provides valuable insight into whether Reviva Pharmaceuticals is net buyers or sellers over its current business cycle. Note, Reviva Pharmaceuticals insiders must abide by specific rules, including filing SEC forms every time they buy or sell Reviva Pharmaceuticals'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Narayan Prabhu over two months ago Acquisition by Narayan Prabhu of 96519 shares of Reviva Pharmaceuticals at 1.2 subject to Rule 16b-3 |
Reviva Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of (2.3395) % which means that it has lost $2.3395 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (17.9506) %, meaning that it generated substantial loss on money invested by shareholders. Reviva Pharmaceuticals' management efficiency ratios could be used to measure how well Reviva Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to climb to about (1.6 M) in 2024. Return On Capital Employed is likely to climb to about (5.8 M) in 2024. At this time, Reviva Pharmaceuticals' Other Assets are fairly stable compared to the past year. Other Current Assets is likely to climb to about 504.5 K in 2024, whereas Total Assets are likely to drop slightly above 18.2 M in 2024.Similar Executives
| Found 1 records | INSIDER Age | ||
| Laxminarayan Bhat | Reviva Pharmaceuticals Holdings | 59 | |
Management Performance
| Return On Equity | -17.95 | ||||
| Return On Asset | -2.34 |
Reviva Pharmaceuticals Management Team
Elected by the shareholders, the Reviva Pharmaceuticals' board of directors comprises two types of representatives: Reviva Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Reviva. The board's role is to monitor Reviva Pharmaceuticals' management team and ensure that shareholders' interests are well served. Reviva Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Reviva Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Marc Cantillon, Chief Officer | ||
| Narayan Prabhu, Chief Officer | ||
| Laxminarayan Bhat, CEO, Founder |
Reviva Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Reviva Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -17.95 | ||||
| Return On Asset | -2.34 | ||||
| Number Of Shares Shorted | 14.36 K | ||||
| EBITDA | (1.95 M) | ||||
| Net Income | (39.26 M) | ||||
| Cash And Equivalents | 353.26 K | ||||
| Cash Per Share | 0.02 X | ||||
| Total Debt | 17.98 M | ||||
| Current Ratio | 0.03 X | ||||
| Book Value Per Share | 0.20 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Reviva Stock Analysis
When running Reviva Pharmaceuticals' price analysis, check to measure Reviva Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reviva Pharmaceuticals is operating at the current time. Most of Reviva Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reviva Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reviva Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reviva Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.